Goto Aya, Mouri Akihiro, Nagai Tomoko, Yoshimi Akira, Ukigai Mako, Tsubai Tomomi, Hida Hirotake, Ozaki Norio, Noda Yukihiro
Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.
Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
Toxicol Appl Pharmacol. 2016 Sep 1;306:8-16. doi: 10.1016/j.taap.2016.06.028. Epub 2016 Jun 28.
Clozapine is an effective antipsychotic for treatment-resistant schizophrenia, but can cause fatal hematopoietic toxicity as agranulocytosis. To elucidate the mechanism of hematopoietic toxicity induced by clozapine, we developed an in vitro assay system using HL-60 cells, and investigated the effect on hematopoiesis. HL-60 cells were differentiated by all-trans retinoic acid (ATRA) into three states according to the following hematopoietic process: undifferentiated HL-60 cells, those undergoing granulocytic ATRA-differentiation, and ATRA-differentiated granulocytic cells. Hematopoietic toxicity was evaluated by analyzing cell survival, cell proliferation, granulocytic differentiation, apoptosis, and necrosis. In undifferentiated HL-60 cells and ATRA-differentiated granulocytic cells, both clozapine (50 and 100μM) and doxorubicin (0.2µM) decreased the cell survival rate, but olanzapine (1-100µM) did not. Under granulocytic differentiation for 5days, clozapine, even at a concentration of 25μM, decreased survival without affecting granulocytic differentiation, increased caspase activity, and caused apoptosis rather than necrosis. Histamine H4 receptor mRNA was expressed in HL-60 cells, whereas the expression decreased under granulocytic ATRA-differentiation little by little. Both thioperamide, a histamine H4 receptor antagonist, and DEVD-FMK, a caspase-3 inhibitor, exerted protection against clozapine-induced survival rate reduction, but not of live cell counts. 4-Methylhistamine, a histamine H4 receptor agonist, decreased the survival rate and live cell counts, as did clozapine. HL-60 cells under granulocytic differentiation are vulnerable under in vitro assay conditions to hematopoietic toxicity induced by clozapine. Histamine H4 receptor is involved in the development of clozapine-induced hematopoietic toxicity through apoptosis, and may be a potential target for preventing its occurrence through granulocytic differentiation.
氯氮平是一种治疗难治性精神分裂症的有效抗精神病药物,但可导致致命的造血毒性,如粒细胞缺乏症。为了阐明氯氮平诱导造血毒性的机制,我们开发了一种使用HL-60细胞的体外检测系统,并研究了其对造血的影响。HL-60细胞根据以下造血过程通过全反式维甲酸(ATRA)分化为三种状态:未分化的HL-60细胞、经历粒细胞ATRA分化的细胞和ATRA分化的粒细胞。通过分析细胞存活、细胞增殖、粒细胞分化、凋亡和坏死来评估造血毒性。在未分化的HL-60细胞和ATRA分化的粒细胞中,氯氮平(50和100μM)和阿霉素(0.2μM)均降低了细胞存活率,但奥氮平(1-100μM)则没有。在粒细胞分化5天后,氯氮平即使在25μM的浓度下也会降低存活率,而不影响粒细胞分化,增加半胱天冬酶活性,并导致凋亡而非坏死。组胺H4受体mRNA在HL-60细胞中表达,而在粒细胞ATRA分化过程中表达逐渐降低。组胺H4受体拮抗剂硫代哌啶和半胱天冬酶-3抑制剂DEVD-FMK均对氯氮平诱导的存活率降低具有保护作用,但对活细胞计数没有保护作用。组胺H4受体激动剂4-甲基组胺降低了存活率和活细胞计数,氯氮平也是如此。在体外检测条件下,粒细胞分化的HL-60细胞对氯氮平诱导的造血毒性敏感。组胺H4受体通过凋亡参与氯氮平诱导的造血毒性的发生,可能是通过粒细胞分化预防其发生的潜在靶点。